These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18087777)

  • 1. Indian biotech's bumpy road.
    Basu P
    Nature; 2007 Nov; 450(7169):580-1. PubMed ID: 18087777
    [No Abstract]   [Full Text] [Related]  

  • 2. California dreaming: San Diego.
    Smaglik P
    Nature; 2003 Mar; 422(6928):240-1. PubMed ID: 12634799
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotech's balancing act.
    Smaglik P
    Nature; 2003 May; 423(6937):363. PubMed ID: 12748656
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotech jobs are still around despite the recent bumpy ride.
    Smaglik P; Smith A
    Nature; 2002 Jul; 418(6893):4-5. PubMed ID: 12097871
    [No Abstract]   [Full Text] [Related]  

  • 5. Corridor at the crossroads: Michigan.
    Smaglik P
    Nature; 2002 Nov; 420(6913):4-5. PubMed ID: 12447399
    [No Abstract]   [Full Text] [Related]  

  • 6. Hiring foreign workers: what you need to know.
    Lopez JR
    Nat Biotechnol; 2001 Jun; 19(6):595. PubMed ID: 11385471
    [No Abstract]   [Full Text] [Related]  

  • 7. Fourth quarter lag in biotech hiring.
    Francisco M
    Nat Biotechnol; 2010 Feb; 28(2):179. PubMed ID: 20139961
    [No Abstract]   [Full Text] [Related]  

  • 8. Indian players in some of IT and biotech's top teams.
    Mehrotra M
    Nature; 2005 Oct; 437(7061):951. PubMed ID: 16222273
    [No Abstract]   [Full Text] [Related]  

  • 9. US biotechnology companies and foreign nationals: the changing dynamics of access to H-1B visas.
    Dahms AS; Trow SC
    Nat Biotechnol; 2005 May; 23(5):629-30. PubMed ID: 15877077
    [No Abstract]   [Full Text] [Related]  

  • 10. Effective recruitment strategies for the biotechnology industry.
    McGrath D
    Nat Biotechnol; 2002 Mar; 20(3):317. PubMed ID: 11875439
    [No Abstract]   [Full Text] [Related]  

  • 11. Crystal gazing: biotech's financial outlook: the biotech analyst's view.
    Schmidt E
    Nat Biotechnol; 2006 Mar; 24(3):261-2. PubMed ID: 16525376
    [No Abstract]   [Full Text] [Related]  

  • 12. Will industry play a bigger role in Europe's aims to promote mobility among postdocs?
    Hinck S; Schiermeier Q
    Nature; 2003 Jan; 421(6920):296-7. PubMed ID: 12529652
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotech's billion dollar breakthrough.
    Stipp D
    Fortune; 2003 May; 147(10):96-8, 100, 103. PubMed ID: 12776500
    [No Abstract]   [Full Text] [Related]  

  • 14. New immigration laws affect US biotechnology.
    Cowan PS
    Nat Biotechnol; 2003 Jun; 21(6):713-4. PubMed ID: 12776155
    [No Abstract]   [Full Text] [Related]  

  • 15. French lessons.
    Smaglik P
    Nature; 2005 Jun; 435(7043):849. PubMed ID: 15944711
    [No Abstract]   [Full Text] [Related]  

  • 16. Big pharma swallows biotech's pride.
    Huggett B
    Nat Biotechnol; 2008 Sep; 26(9):955-6. PubMed ID: 18779785
    [No Abstract]   [Full Text] [Related]  

  • 17. Biotech in Bangalore.
    Russo G
    Nature; 2008 Apr; 452(7187):660-1. PubMed ID: 18389533
    [No Abstract]   [Full Text] [Related]  

  • 18. Taiwan: Biotech vision.
    Cyranoski D
    Nature; 2003 Feb; 421(6923):672-3. PubMed ID: 12571608
    [No Abstract]   [Full Text] [Related]  

  • 19. Biotech's perfect storm.
    Karberg S
    Cell; 2009 Aug; 138(3):413-5. PubMed ID: 19665960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malyasian biotechnology: the valley of ghosts.
    Cyranoski D
    Nature; 2005 Aug; 436(7051):620-1. PubMed ID: 16079812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.